Shares of Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $18.97, but opened at $18.51. Ascentage Pharma Group International shares last traded at $18.46, with a volume of 680 shares trading hands.
Analyst Upgrades and Downgrades
Separately, JPMorgan Chase & Co. initiated coverage on Ascentage Pharma Group International in a report on Thursday. They issued an “overweight” rating for the company.
Get Our Latest Analysis on Ascentage Pharma Group International
Ascentage Pharma Group International Trading Up 10.0 %
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Read More
- Five stocks we like better than Ascentage Pharma Group International
- What is a penny stock? A comprehensive guide
- Ibotta Stock: Why the Buyback Looks Like a Bullish Bet
- Investing in Travel Stocks Benefits
- Joby Aviation Stock: Analyst Confidence and Smart Money Align
- The Risks of Owning Bonds
- 3 Momentum Stocks Near 52-Week Highs to Watch for More Growth
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
